Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7
1 clinical trials · Condition
◉ Watch Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7
| Record | Firm | Date |
|---|---|---|
| Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer (NCT03601507) | University of Arizona | 2019-03-11 |
Track Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7 automatically
Every clearance here is in the API, with alerts when new ones post.